Long Island Wealth Management’s Innovator Emerging Markets Power Buffer ETF January EJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.89M Buy
232,619
+7,711
+3% +$266K 3.66% 8
2025
Q4
$7.6M Buy
224,908
+1,826
+0.8% +$61.1K 3.59% 8
2025
Q3
$7.41M Sell
223,082
-1,015
-0.5% -$33.1K 3.61% 8
2025
Q2
$7.18M Buy
224,097
+75,089
+50% +$2.31M 3.73% 7
2025
Q1
$4.51M Buy
149,008
+16,884
+13% +$506K 2.74% 12
2024
Q4
$3.89M Buy
132,124
+24,984
+23% +$766K 2.43% 14
2024
Q3
$3.36M Buy
107,140
+22,286
+26% +$672K 2.21% 15
2024
Q2
$2.53M Sell
84,854
-534
-0.6% -$15.7K 1.79% 18
2024
Q1
$2.47M Buy
85,388
+1,653
+2% +$46.9K 1.75% 18
2023
Q4
$2.4M Buy
+83,735
New +$2.31M 1.71% 17

Other funds holding EJAN

Long Island Wealth Management's EJAN Position: Q1 2026 in Review

Long Island Wealth Management increased its Innovator Emerging Markets Power Buffer ETF January (EJAN) stake by 3.4% in Q1 2026, buying an estimated $266K and bringing the position to 232,619 shares worth $7.89M. The position accounts for 3.66% of the portfolio, ranked #8.

Long Island Wealth Management first reported a position in EJAN in Q4 2023 and has held it in 10 quarters since. 88 funds tracked by Wall St. Rank hold EJAN as of Q1 2026.

  • Long Island Wealth Management held 232,619 shares of Innovator Emerging Markets Power Buffer ETF January worth $7.89M as of Q1 2026.
  • Long Island Wealth Management bought 7,711 Innovator Emerging Markets Power Buffer ETF January shares in Q1 2026, an estimated $266K.
  • Innovator Emerging Markets Power Buffer ETF January made up 3.66% of Long Island Wealth Management's portfolio in Q1 2026, its #8 holding.
  • Long Island Wealth Management first reported a position in Innovator Emerging Markets Power Buffer ETF January in Q4 2023 and has held it in 10 quarters since.
  • 88 funds tracked by Wall St. Rank held Innovator Emerging Markets Power Buffer ETF January as of Q1 2026.

Based on Long Island Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.